Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Pre-existing disease in pregnancy

From Wikipedia, the free encyclopedia

Apre-existing disease in pregnancy is a disease that is not directly caused by thepregnancy, in contrast to variouscomplications of pregnancy, but which may become worse or be a potential risk to the pregnancy (such as causing pregnancy complications). A major component of this risk can result from the necessary use ofdrugs in pregnancy to manage the disease.

In such circumstances, women who wish to continue with a pregnancy require extra medical care, often from an interdisciplinary team. Such a team might include (besides an obstetrician) a specialist in the disorder and other practitioners (for example,maternal-fetal specialists orobstetric physicians,dieticians, etc.).[MMHE 1]

Cardiovascular problems

[edit]

Chronic hypertension

[edit]

Chronic hypertension in pregnancy can lead to increased complications for both the mother and fetus. Maternal complications include superimposed pre-eclampsia and caesarean delivery. Fetal complications include preterm delivery, low birth weight, and death. Increasing rates of obesity and metabolic syndrome play a key role in the increased prevalence of chronic hypertension and associated complications.[1] Women who have chronic hypertension before their pregnancy are at increased risk of complications such aspremature birth,low birthweight orstillbirth.[2] Women who have high blood pressure and had complications in their pregnancy have three times the risk of developingcardiovascular disease compared to women with normal blood pressure who had no complications in pregnancy. Monitoring pregnant women's blood pressure can help prevent both complications and future cardiovascular diseases.[3][4] While high blood pressure treatment has been shown to decrease the incidence of severe hypertension during pregnancy, there was no significant difference in pregnancy complications (for example, superimposed pre-eclampsia, stillbrith/neonatal death, small for gestational age).[5]

Hypercoagulability

[edit]
Main article:Hypercoagulability in pregnancy

Hypercoagulability in pregnancy is the propensity of pregnant women to developthrombosis (blood clots), such as a deep vein thrombosis with a potential subsequent pulmonary embolism. Pregnancy itself is a factor ofhypercoagulability (pregnancy-induced hypercoagulability), as a physiologically adaptive mechanism to preventpostpartum bleeding.[6] The pregnancy-associated hypercoagulability is attributed to an increased synthesis of coagulation factors, such as fibrinogen, by the liver through the effects of estrogen.

When combined with any additional underlying hypercoagulable state, the risk of thrombosis or embolism may become substantial.[6] Multiple pre-existing genetic disorders can worsen the hypercoagulable state observed in pregnancy. Examples include:

Valvular heart disease

[edit]
Main article:Valvular heart disease and pregnancy

In the case ofvalvular heart disease in pregnancy, thematernal physiological changes in pregnancy confer additional load on the heart and may lead to complications.

In individuals who require anartificial heart valve, consideration must be made for deterioration of the valve over time (for bioprosthetic valves) versus the risks ofblood clotting in pregnancy with mechanical valves with the resultant need ofdrugs in pregnancy in the form ofanticoagulants.

Endocrine disorders

[edit]

Diabetes mellitus

[edit]
Main article:Diabetes mellitus and pregnancy

Diabetes mellitus and pregnancy deals with the interactions ofdiabetes mellitus (not restricted togestational diabetes) and pregnancy. Risks for the child include miscarriage, growth restriction, growth acceleration, fetal obesity (macrosomia), polyhydramnios, and birth defects.

Thyroid disease

[edit]
Main article:Thyroid disease in pregnancy

Thyroid disease in pregnancy can, if uncorrected, cause adverse effects on fetal and maternal well-being. The deleterious effects of thyroid dysfunction can also extend beyond pregnancy and delivery to affect neurointellectual development in the early life of the child. Demand for thyroid hormones is increased during pregnancy, which may cause a previously unnoticed thyroid disorder to worsen. The most effective way of screening for thyroid dysfunction is not known.[7] A review found that more women were diagnosed with thyroid dysfunction when all pregnant women were tested instead of just testing those at 'high-risk' of thyroid problems (those with family history, signs or symptoms).[7] Finding more women with thyroid dysfunction meant that the women could have treatment and management through their pregnancies. However, the outcomes of the pregnancies were surprisingly similar, so more research is needed to look at the effects of screening all pregnant women for thyroid problems.[7]

Neurological problems

[edit]

Epilepsy

[edit]
Main article:Epilepsy and pregnancy

Women withepilepsy usually have safe, healthypregnancies and healthy babies. However, achieving this requires choosing appropriateanti-seizure medications to maintain seizure control while reducing the risk ofbirth defects caused by the medications.[8] Unplanned pregnancies should beprevented, and pregnancies should be planned up to a year in advance, to allow time to switch to anti-seizure medications that are safer for the baby.[9] Seizures during pregnancy can cause birth defects orpregnancy loss, so anti-seizure medications normally need to be taken during pregnancy.[10] For example,valproic acid is not recommended during pregnancy because of the higher risk ofneurodevelopmental birth defects compared to other medications, so a woman who has been taking valproic acid might try a different medication.[11] Even if anti-seizure medications are not taken, the child has a somewhat increased risk of developing epilepsy, though the overall absolute risk of the child developing epilepsy is usually around 5%.[12]

Infections

[edit]

Vertically transmitted infections

[edit]
Main article:Vertically transmitted infection

Manyinfectious diseases have a risk ofvertical transmission to the fetus, known as TORCH infections. Examples based on the TORCHES acronym include:

Infections in pregnancy also raise particular concerns about whether or not to usedrugs in pregnancy (that is,antibiotics orantivirals) to treat them. For example, pregnant women who contractH1N1 influenza infection are recommended to receive antiviral therapy with eitheroseltamivir (which is the preferred medication) orzanamivir.[16] Bothamantadine andrimantadine have been found to beteratogenic andembryotoxic when given at high doses in animal studies.[16]

Candidal vulvovaginitis

[edit]

In pregnancy, changes in the levels of female sex hormones, such asestrogen, make a woman more likely to developcandidal vulvovaginitis. During pregnancy, theCandida fungus is more prevalent (common), and recurrent infection is also more likely.[17] There is no clear evidence that treatment of asymptomatic candidal vulvovaginitis in pregnancy reduces the risk ofpreterm birth.[18] Candidal vulvovaginitis in pregnancy should be treated with intravaginalclotrimazole ornystatin for at least 7 days.[19]

Bacterial vaginosis

[edit]

Bacterial vaginosis is an imbalance of naturally occurringbacterial flora in the vagina. Bacterial vaginosis occurring during pregnancy may increase the risk ofpregnancy complications, most notablypremature birth ormiscarriage.[20] However, this risk is small overall and appears more significant in women who have had such complications in an earlier pregnancy.[21]

Other autoimmune disorders

[edit]

Celiac disease

[edit]

Untreatedceliac disease can causespontaneous abortion (miscarriage),intrauterine growth restriction,small for gestational age,low birthweight andpreterm birth. Often, reproductive disorders are the only manifestation of undiagnosed celiac disease, and most cases are not recognized. Complications or failures of pregnancy cannot be explained simply by malabsorption, but by the autoimmune response elicited by the exposure togluten, which causes damage to theplacenta. Thegluten-free diet avoids or reduces the risk of developing reproductive disorders in pregnant women with celiac disease.[22][23] Also, pregnancy can be a trigger for the development of celiac disease in genetically susceptible women who are consuming gluten.[24]

Systemic lupus erythematosus

[edit]
Main article:Systemic lupus erythematosus and pregnancy

Systemic lupus erythematosus and pregnancy confers an increased rate of fetal deathin utero andspontaneous abortion (miscarriage), as well as ofneonatal lupus.

Behçet's disease

[edit]

Pregnancy does not worsen the course ofBehçet's disease and may ameliorate it.[25][26] Still, there is substantial variability in clinical course between patients and even for different pregnancies in the same patient.[25] Also, the other way around, Behçet's disease confers an increased risk ofpregnancy complications,miscarriage andCesarean section.[26]

Multiple sclerosis

[edit]

Being pregnant decreases the risk of relapse inmultiple sclerosis; however, during the first months after delivery, the risk increases.[27] Overall, pregnancy does not seem to influence long-term disability.[27] Multiple sclerosis does not increase the risk ofcongenital abnormality ormiscarriage.[28][29]

Mental health

[edit]

Depression in pregnancy

[edit]

The effects of depression during pregnancy are difficult to parse from depression before pregnancy, as the symptoms of the two overlap. However, the biggest risk factor for depression during pregnancy is a prior history of depression.[30] Most of the research is focused on the consequences of untreated depression regardless if the depression developed during pregnancy or if it was there before conception. Untreated depression has been linked to premature birth, low birth weight, fetal growth restriction, and postnatal complications.[30] On the other hand, however, anti-depressant medications also come with a small risk of pre-term birth, low birth weight, and persistent pulmonary hypertension.[31][30]

Respiratory disease

[edit]

Asthma

[edit]

In the United States, theprevalence of asthma among pregnant women is between 8.4% and 8.8%.[32] Asthma in pregnant women is strongly associated with multiple adverse health outcomes, including pre-eclampsia, preterm birth, and low birth weight.[33][34] Other conditions such as gestational diabetes, placenta previa, and hemorrhage are inconsistently correlated to asthma.[35] Additionally, women with Asthma face a higher likelihood of complications during labor and delivery, such as breech presentation and caesarean delivery.[36] Poorly controlled and severe asthma may exacerbate conditions associated with maternal and neonate morbidity and mortality.[35][37] Asthma treatment recommendations during pregnancy are similar to those in non-pregnant women.[38]

As of 2018, Asthma was the most prevalent respiratory disorder to complicate pregnancy, remaining a high-risk condition despite therapeutic advancements.[39] Preventing asthma exacerbations during pregnancy is crucial to reduce the risk of complications and poor outcomes.[36]

The course of asthma during pregnancy

[edit]

The course of asthma during pregnancy can vary, with some patients experiencing worsening symptoms while others see improvement.

As of 2006, it was believed the course of asthma during pregnancy varied with a similar proportion of women improving, remaining stable, or worsening.[40] However, as of 2013, it was found that deterioration may manifest in approximately 20% of women, improvement in around 30%, and no significant change observed in the remaining 50%.[41]

Structural (congenital) abnormalities of the uterus

[edit]

Structural abnormalities of the uterus include conditions like a septate uterus, a bicornuate uterus, an arcuate uterus, and a didelphys uterus.[42] Most of these abnormalities occur when the Müllerian ducts are fused improperly or incompletely. Women with these congenital abnormalities are usually unaware, as these conditions do not usually present any symptoms. During pregnancy, these conditions are associated with infertility, preterm birth, fetal malpresentation, and early miscarriages. Among these uterine abnormalities, those with canalization defects, i.e., not having a normal uterine canal, such as septate defects, have the worst pregnancy outcomes.[42] Surgical treatment is only recommended for individuals who have had recurrent miscarriages and have a septate uterus; however, the risks of surgery, especially scarring of the womb, should be considered. Further evidence from randomized controlled trials is required to establish conclusively whether surgery is the better option when its risks and rewards are compared with the risks of adverse pregnancy outcomes.[42]

Others

[edit]

The following conditions may also become worse or be a potential risk to the pregnancy:

References

[edit]
  1. ^Bramham, Kate; Parnell, Bethany; Nelson-Piercy, Catherine; Seed, Paul T; Poston, Lucilla; Chappell, Lucy C (2014-04-15)."Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis".The BMJ.348 g2301.doi:10.1136/bmj.g2301.ISSN 0959-8138.PMC 3988319.PMID 24735917.
  2. ^Al Khalaf, Sukainah Y.; O'Reilly, Éilis J.; Barrett, Peter M.; B. Leite, Debora F.; Pawley, Lauren C.; McCarthy, Fergus P.; Khashan, Ali S. (2021-05-04)."Impact of Chronic Hypertension and Antihypertensive Treatment on Adverse Perinatal Outcomes: Systematic Review and Meta-Analysis".Journal of the American Heart Association.10 (9) e018494.doi:10.1161/JAHA.120.018494.ISSN 2047-9980.PMC 8200761.PMID 33870708.
  3. ^"Pregnancy complications increase the risk of heart attacks and stroke in women with high blood pressure".NIHR Evidence (Plain English summary). National Institute for Health and Care Research. 2023-11-21.doi:10.3310/nihrevidence_60660.
  4. ^Al Khalaf, Sukainah; Chappell, Lucy C.; Khashan, Ali S.; McCarthy, Fergus P.; O'Reilly, Éilis J. (12 May 2023)."Association Between Chronic Hypertension and the Risk of 12 Cardiovascular Diseases Among Parous Women: The Role of Adverse Pregnancy Outcomes".Hypertension.80 (7):1427–1438.doi:10.1161/HYPERTENSIONAHA.122.20628.ISSN 0194-911X.
  5. ^Webster, Louise M.; Conti-Ramsden, Frances; Seed, Paul T.; Webb, Andrew J.; Nelson-Piercy, Catherine; Chappell, Lucy C. (2017-05-17)."Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis".Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease.6 (5).doi:10.1161/JAHA.117.005526.ISSN 2047-9980.PMC 5524099.PMID 28515115.
  6. ^abPage 264 in:Gresele, Paolo (2008).Platelets in hematologic and cardiovascular disorders: a clinical handbook. Cambridge, UK: Cambridge University Press.ISBN 978-0-521-88115-9.
  7. ^abcSpencer, L; Bubner, T; Bain, E; Middleton, P (21 September 2015)."Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health".The Cochrane Database of Systematic Reviews.2015 (9) CD011263.doi:10.1002/14651858.CD011263.pub2.PMC 9233937.PMID 26387772.
  8. ^Voinescu, P. Emanuela; Pennell, Page B. (October 2015)."Management of epilepsy during pregnancy".Expert Review of Neurotherapeutics.15 (10):1171–1187.doi:10.1586/14737175.2015.1083422.ISSN 1744-8360.PMC 6411070.PMID 26416395.
  9. ^Tomson, Torbjörn; Battino, Dina; Perucca, Emilio (April 2019). "Teratogenicity of antiepileptic drugs".Current Opinion in Neurology.32 (2):246–252.doi:10.1097/WCO.0000000000000659.ISSN 1473-6551.PMID 30664067.S2CID 58608931.
  10. ^Tomson, Torbjörn; Battino, Dina; Bromley, Rebecca; Kochen, Silvia; Meador, Kimford; Pennell, Page; Thomas, Sanjeev V. (2019-12-01). "Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy".Epileptic Disorders: International Epilepsy Journal with Videotape.21 (6):497–517.doi:10.1684/epd.2019.1105.hdl:11336/119061.ISSN 1950-6945.PMID 31782407.
  11. ^Błaszczyk, Barbara; Miziak, Barbara; Pluta, Ryszard; Czuczwar, Stanisław J. (2022-01-25)."Epilepsy in Pregnancy-Management Principles and Focus on Valproate".International Journal of Molecular Sciences.23 (3): 1369.doi:10.3390/ijms23031369.ISSN 1422-0067.PMC 8836209.PMID 35163292.
  12. ^Dreier, Julie W.; Ellis, Colin A.; Berkovic, Samuel F.; Cotsapas, Chris; Ottman, Ruth; Christensen, Jakob (2020-11-29)."Epilepsy risk in offspring of affected parents; a cohort study of the "maternal effect" in epilepsy".Annals of Clinical and Translational Neurology.8 (1):153–162.doi:10.1002/acn3.51258.ISSN 2328-9503.PMC 7818075.PMID 33249752.
  13. ^K E Ugen; J J Goedert; J Boyer; Y Refaeli; I Frank; W V Williams; A Willoughby; S Landesman; H Mendez; A Rubinstein (June 1992)."Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1".J Clin Invest.89 (6):1923–1930.doi:10.1172/JCI115798.PMC 295892.PMID 1601999.
  14. ^Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D, Hertzmark E, Coley J, Garland M, Kapiga S, Antelman G, Essex M, Spiegelman D (1999)."Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania".Journal of Acquired Immune Deficiency Syndromes.23 (3):246–254.doi:10.1097/00042560-200003010-00006.PMID 10839660.S2CID 35936352.
  15. ^Lee MJ, Hallmark RJ, Frenkel LM, Del Priore G (1998). "Maternal syphilis and vertical perinatal transmission of human immunodeficiency virus type-1 infection".International Journal of Gynecology & Obstetrics.63 (3):246–254.doi:10.1016/S0020-7292(98)00165-9.PMID 9989893.S2CID 22297001.
  16. ^abHealth Care Guideline: Routine Prenatal Care. Fourteenth Edition.Archived 2008-07-05 at theWayback Machine By the Institute for Clinical Systems Improvement. July 2010.
  17. ^Sobel, JD (9 June 2007). "Vulvovaginal candidosis".Lancet.369 (9577):1961–71.doi:10.1016/S0140-6736(07)60917-9.PMID 17560449.S2CID 33894309.
  18. ^Roberts, C. L.; Rickard, K.; Kotsiou, G.; Morris, J. M. (2011)."Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: An open-label pilot randomized controlled trial".BMC Pregnancy and Childbirth.11: 18.doi:10.1186/1471-2393-11-18.PMC 3063235.PMID 21396090.
  19. ^Ratcliffe, Stephen D.; Baxley, Elizabeth G.; Cline, Matthew K. (2008).Family Medicine Obstetrics. Elsevier Health Sciences. p. 273.ISBN 978-0-323-04306-9.
  20. ^"Bacterial Vaginosis Treatment and Care". Centers for Disease Control and Prevention. Retrieved24 October 2020.
  21. ^Bacterial vaginosis fromNational Health Service, UK. Page last reviewed: 03/10/2013
  22. ^Tersigni, C.; Castellani, R.; de Waure, C.; Fattorossi, A.; De Spirito, M.; Gasbarrini, A.; Scambia, G.; Di Simone, N. (2014)."Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms".Human Reproduction Update.20 (4):582–593.doi:10.1093/humupd/dmu007.hdl:10807/56796.ISSN 1355-4786.PMID 24619876.
  23. ^Saccone G, Berghella V, Sarno L, Maruotti GM, Cetin I, Greco L, Khashan AS, McCarthy F, Martinelli D, Fortunato F, Martinelli P (Oct 9, 2015). "Celiac disease and obstetric complications: a systematic review and metaanalysis".Am J Obstet Gynecol.214 (2):225–34.doi:10.1016/j.ajog.2015.09.080.hdl:11369/330101.PMID 26432464.
  24. ^"The Gluten Connection". Health Canada. May 2009. Retrieved1 October 2013.
  25. ^abUzun, S.; Alpsoy, E.; Durdu, M.; Akman, A. (2003). "The clinical course of Behçet's disease in pregnancy: A retrospective analysis and review of the literature".The Journal of Dermatology.30 (7):499–502.doi:10.1111/j.1346-8138.2003.tb00423.x.PMID 12928538.S2CID 12860697.
  26. ^abJadaon, J.; Shushan, A.; Ezra, Y.; Sela, H. Y.; Ozcan, C.; Rojansky, N. (2005)."Behcet's disease and pregnancy".Acta Obstetricia et Gynecologica Scandinavica.84 (10):939–944.doi:10.1111/j.0001-6349.2005.00761.x.PMID 16167908.S2CID 22363654.
  27. ^abCompston A, Coles A (October 2008). "Multiple sclerosis".Lancet.372 (9648):1502–17.doi:10.1016/S0140-6736(08)61620-7.PMID 18970977.S2CID 195686659.
  28. ^Multiple Sclerosis: Pregnancy Q&AArchived 2013-10-19 at theWayback Machine fromCleveland Clinic, retrieved January 2014.
  29. ^Ramagopalan, S. V.; Guimond, C.; Criscuoli, M.; Dyment, D. A.; Orton, S. M.; Yee, I. M.; Ebers, G. C.; Sadovnick, D. (2010)."Congenital Abnormalities and Multiple Sclerosis".BMC Neurology.10: 115.doi:10.1186/1471-2377-10-115.PMC 3020672.PMID 21080921.
  30. ^abcPearlstein, Teri (2015-07-01)."Depression during Pregnancy".Best Practice & Research Clinical Obstetrics & Gynaecology.29 (5):754–764.doi:10.1016/j.bpobgyn.2015.04.004.ISSN 1521-6934.PMID 25976080.S2CID 2932772.
  31. ^Becker, Madeleine; Weinberger, Tal; Chandy, Ann; Schmukler, Sarah (2016-02-15). "Depression During Pregnancy and Postpartum".Current Psychiatry Reports.18 (3): 32.doi:10.1007/s11920-016-0664-7.ISSN 1535-1645.PMID 26879925.S2CID 38045296.
  32. ^Kwon, Helen L.; Triche, Elizabeth W.; Belanger, Kathleen; Bracken, Michael B. (2006-02-01)."The Epidemiology of Asthma During Pregnancy: Prevalence, Diagnosis, and Symptoms".Immunology and Allergy Clinics of North America.26 (1):29–62.doi:10.1016/j.iac.2005.11.002.ISSN 0889-8561.PMID 16443142.
  33. ^Murphy, V. E.; Namazy, J. A.; Powell, H.; Schatz, M.; Chambers, C.; Attia, J.; Gibson, P. G. (2011)."A meta-analysis of adverse perinatal outcomes in women with asthma".BJOG: An International Journal of Obstetrics & Gynaecology.118 (11):1314–1323.doi:10.1111/j.1471-0528.2011.03055.x.hdl:1959.13/1052131.ISSN 1471-0528.PMID 21749633.S2CID 30009033.
  34. ^Mendola, Pauline; Laughon, S. Katherine; Männistö, Tuija I.; Leishear, Kira; Reddy, Uma M.; Chen, Zhen; Zhang, Jun (February 2013)."Obstetric complications among US women with asthma".American Journal of Obstetrics and Gynecology.208 (2): 127.e1–127.e8.doi:10.1016/j.ajog.2012.11.007.ISSN 0002-9378.PMC 3557554.PMID 23159695.
  35. ^abDombrowski, Mitchell P.; Schatz, Michael; Wise, Robert; Momirova, Valerija; Landon, Mark; Mabie, William; Newman, Roger B.; McNellis, Donald; Hauth, John C.; Lindheimer, Marshall; Caritis, Steve N.; Leveno, Kenneth J.; Meis, Paul; Miodovnik, Menachem; Wapner, Ronald J.; Paul, Richard H.; Varner, Michael W.; o'Sullivan, Mary Jo; Thurnau, Gary R.; Conway, Deborah L. (2004). "Asthma During Pregnancy".Obstetrics & Gynecology.103 (1):5–12.doi:10.1097/01.AOG.0000103994.75162.16.PMID 14704237.S2CID 43265653.
  36. ^abAli, Z.; Hansen, A. V.; Ulrik, C. S. (2016-05-18)."Exacerbations of asthma during pregnancy: Impact on pregnancy complications and outcome".Journal of Obstetrics and Gynaecology.36 (4):455–461.doi:10.3109/01443615.2015.1065800.ISSN 0144-3615.PMID 26467747.S2CID 207436121.
  37. ^Enriquez, Rachel; Griffin, Marie R.; Carroll, Kecia N.; Wu, Pingsheng; Cooper, William O.; Gebretsadik, Tebeb; Dupont, William D.; Mitchel, Edward F.; Hartert, Tina V. (September 2007)."Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes".Journal of Allergy and Clinical Immunology.120 (3):625–630.doi:10.1016/j.jaci.2007.05.044.ISSN 0091-6749.PMID 17658591.
  38. ^Busse, William W. (January 2005). "NAEPP Expert Panel ReportManaging Asthma During Pregnancy: Recommendations for Pharmacologic Treatment—2004 Update".Journal of Allergy and Clinical Immunology.115 (1):34–46.doi:10.1016/j.jaci.2004.10.023.ISSN 0091-6749.PMID 15637545.
  39. ^Bonham, Catherine A.; Patterson, Karen C.; Strek, Mary E. (February 2018)."Asthma Outcomes and Management During Pregnancy".Chest.153 (2):515–527.doi:10.1016/j.chest.2017.08.029.ISSN 0012-3692.PMC 5815874.PMID 28867295.
  40. ^N.C. Thomson, G. Vallance, in Encyclopedia of Respiratory Medicine, 2006, Pages 206-215
  41. ^Neil Pearce, Jeroen Douwes, in Women and Health (Second Edition), 2013
  42. ^abcAkhtar, M. A.; Saravelos, S. H.; Li, T. C.; Jayaprakasan, K. (2020)."Reproductive Implications and Management of Congenital Uterine Anomalies".BJOG: An International Journal of Obstetrics & Gynaecology.127 (5):e1–e13.doi:10.1111/1471-0528.15968.ISSN 1471-0528.PMID 31749334.
  43. ^Li, D; Liu, L; Odouli, R (2009)."Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study".Human Reproduction.24 (1):146–153.doi:10.1093/humrep/den342.PMID 18948314.
  44. ^Getahun, D; Ananth, CV; Peltier, MR; Smulian, JC; Vintzileos, AM (2006). "Acute and chronic respiratory diseases in pregnancy: associations with placental abruption".American Journal of Obstetrics and Gynecology.195 (4):1180–4.doi:10.1016/j.ajog.2006.07.027.PMID 17000252.
  45. ^Dombrowski, MP (2006). "Asthma and pregnancy".Obstetrics and Gynecology.108 (3 Pt 1):667–81.doi:10.1097/01.AOG.0000235059.84188.9c.PMID 16946229.
  46. ^Louik, C; Schatz, M;Hernández-Díaz, S; Werler, MM; Mitchell, AA (2010)."Asthma in Pregnancy and its Pharmacologic Treatment".Annals of Allergy, Asthma & Immunology.105 (2):110–7.doi:10.1016/j.anai.2010.05.016.PMC 2953247.PMID 20674820.
  1. ^Merck."Overview of Disease During Pregnancy".Merck Manual Home Health Handbook. Merck Sharp & Dohme.
  2. ^Merck."Cancer during pregnancy".Merck Manual Home Health Handbook. Merck Sharp & Dohme. Archived fromthe original on 2015-03-28. Retrieved2013-08-13.
  3. ^Merck."High blood pressure during pregnancy".Merck Manual Home Health Handbook. Merck Sharp & Dohme. Archived fromthe original on 2015-03-02. Retrieved2013-08-13.
  4. ^Merck."Liver and gallbladder disorders during pregnancy".Merck Manual Home Health Handbook. Merck Sharpe & Dohme. Archived fromthe original on 2015-03-16. Retrieved2013-08-13.
  5. ^Merck."Heart disorders during pregnancy".Merck Manual Home Health Handbook. Merck Sharp & Dohme. Archived fromthe original on 2015-02-21. Retrieved2013-08-13.
  6. ^Merck."Kidney disorders during pregnancy".Merck Manual Home Health Handbook. Merck Sharp & Dohme. Archived fromthe original on 2015-02-21. Retrieved2013-08-13.
  7. ^Merck."Seizure disorders during pregnancy".Merck Manual Home Health Handbook. Merck Sharp & Dohme. Archived fromthe original on 2015-02-21. Retrieved2013-08-13.
  8. ^Merck."Liver and gallbladder disorders during pregnancy".Merck Manual Home Health Handbook. Merck Sharpe & Dohme. Archived fromthe original on 2015-03-16. Retrieved2013-08-13.
Planning
Conception
Testing
Types
Childbirth
Preparation
Roles
Delivery
Prenatal
Anatomy
Development
Care
Procedures
Postpartum
Maternal
Roles
Infant
Obstetric history
Related
Retrieved from "https://en.wikipedia.org/w/index.php?title=Pre-existing_disease_in_pregnancy&oldid=1330034692"
Category:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp